Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine

This publication has 25 references indexed in Scilit:

• Inhibitory potential of acetaminophen and o-, m-, p-aminophenols for development of γ-glutamyltranspeptidase-positive liver cell foci in rats pretreated with diethylnitrosamine
  Cancer Letters, 1985
• Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine
  Cancer Letters, 1984
• Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
  Environmental Health Perspectives, 1983
• Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of γ-glutamyl transpeptidase-positive foci development in the liver of rats
  Carcinogenesis: Integrative Cancer Research, 1983
• Interference with Dimethylhydrazine Induction of Colon Tumors in Mice by ε-Aminocaproic Acid
  Science, 1982
• Effect of Indomethacin on Intestinal Tumors Induced in Rats by the Acetate Derivative of Dimethylnitrosamine
  Science, 1981
• Inhibitory effect of 4,4′-diaminodiphenylmethane on liver, kidney and bladder carcinogenesis in rats ingesting N-ethyl-N-hydroxyethylnitrosamine or N-butyl-N-(4-hydroxybutyl)nitros-amine
  Carcinogenesis: Integrative Cancer Research, 1981
• Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs
  British Journal of Cancer, 1980
• Mechanism of inhibition of tumour growth by aspirin and indomethacin
  British Journal of Cancer, 1978
• Prostaglandins from tumours of human large bowel
  British Journal of Cancer, 1977